FIGURE 3.
(a) Overall survival in crizotinib‐resistant patients (n = 52). (b) Overall survival in overall population (n = 61). (c) Time to treatment failure during treatment with crizotinib to alectinib in the overall population (n = 61)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.